Comparaison de deux cas d'ostéodystrophie rénale sévère chez l'enfant, traités par la 1 alpha hydroxycholecalciferol (1 alpha OHD)

J. M. Chantraine; J. C. Davin; L. Lambrechts; G. Heynen

Comparaison de deux cas d'ostéodystrophie rénale sévère chez l'enfant, traités par la 1 alpha hydroxycholecalciferol (1 alpha OHD)

J. M. Chantraine
, J. C. Davin
, L. Lambrechts
, G. Heynen

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Two children suffering from renal osteodystrophy were treated by 1 alpha hydroxycholecalciferol (1 alpha OHD3) 1 microgr. each day, for 18 months. In both the level alkaline phosphatase decreased at the same time as endogenous immunoreactive CT increased, iPTH did not change steadily, whereas plasma creatinine rise. As plasma calcium concentration did not increase, it is suggested that the increase in endogenous CT concentration is a part of the favourable response to the treatment by 1 alpha OHD3

Original language	English
Pages (from-to)	161-162
Journal	Annales d endocrinologie
Volume	40
Issue number	2
Publication status	Published - 1979

Cite this

@article{7499252965b74cf0b1d579e8c618e103,

title = "Comparaison de deux cas d'ost{\'e}odystrophie r{\'e}nale s{\'e}v{\`e}re chez l'enfant, trait{\'e}s par la 1 alpha hydroxycholecalciferol (1 alpha OHD)",

abstract = "Two children suffering from renal osteodystrophy were treated by 1 alpha hydroxycholecalciferol (1 alpha OHD3) 1 microgr. each day, for 18 months. In both the level alkaline phosphatase decreased at the same time as endogenous immunoreactive CT increased, iPTH did not change steadily, whereas plasma creatinine rise. As plasma calcium concentration did not increase, it is suggested that the increase in endogenous CT concentration is a part of the favourable response to the treatment by 1 alpha OHD3",

author = "Chantraine, \{J. M.\} and Davin, \{J. C.\} and L. Lambrechts and G. Heynen",

year = "1979",

language = "English",

volume = "40",

pages = "161--162",

journal = "Annales d endocrinologie",

issn = "0003-4266",

publisher = "Elsevier-Masson",

number = "2",

}

TY - JOUR

T1 - Comparaison de deux cas d'ostéodystrophie rénale sévère chez l'enfant, traités par la 1 alpha hydroxycholecalciferol (1 alpha OHD)

AU - Chantraine, J. M.

AU - Davin, J. C.

AU - Lambrechts, L.

AU - Heynen, G.

PY - 1979

Y1 - 1979

N2 - Two children suffering from renal osteodystrophy were treated by 1 alpha hydroxycholecalciferol (1 alpha OHD3) 1 microgr. each day, for 18 months. In both the level alkaline phosphatase decreased at the same time as endogenous immunoreactive CT increased, iPTH did not change steadily, whereas plasma creatinine rise. As plasma calcium concentration did not increase, it is suggested that the increase in endogenous CT concentration is a part of the favourable response to the treatment by 1 alpha OHD3

AB - Two children suffering from renal osteodystrophy were treated by 1 alpha hydroxycholecalciferol (1 alpha OHD3) 1 microgr. each day, for 18 months. In both the level alkaline phosphatase decreased at the same time as endogenous immunoreactive CT increased, iPTH did not change steadily, whereas plasma creatinine rise. As plasma calcium concentration did not increase, it is suggested that the increase in endogenous CT concentration is a part of the favourable response to the treatment by 1 alpha OHD3

M3 - Article

C2 - 475307

SN - 0003-4266

VL - 40

SP - 161

EP - 162

JO - Annales d endocrinologie

JF - Annales d endocrinologie

IS - 2

ER -

Comparaison de deux cas d'ostéodystrophie rénale sévère chez l'enfant, traités par la 1 alpha hydroxycholecalciferol (1 alpha OHD)

Abstract

Fingerprint

Cite this